Clinical Trial Update: A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer [Phase 1]

View source ↗

Summary

This update describes a Phase 1 clinical trial of radiopharmaceuticals 68Ga-R11228 and 177Lu-R11228 in locoregionally recurrent or metastatic hormone-receptor p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 177Lu-R11228
• 68Ga-R11228

Snippet

Sponsor: Radionetics Oncology | Conditions: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer | Phase 1 | Status: RECRUITING